Diego Segura-Rodríguez

Diego Segura-Rodríguez

Auto-generated profile, based on publicly available information

Diego Segura-Rodríguez

Cardiology Department, Hospital Universitario Virgen de las Nieves, Avda. De las Fuerzas Armadas 2, 18014 Granada, Spain

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2019 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Closed access
DSDiego Segura-Rodríguez
Diego Segura-Rodríguez
FBFrancisco José Bermúdez-Jiménez
Francisco José Bermúdez-Jiménez
Víctor CarrielVíctor Carriel
Víctor Carriel
SLSilvia López-Fernández
Silvia López-Fernández
MGMercedes González-Molina
Mercedes González-Molina
JJJuan Jiménez-Jáimez
Juan Jiménez-Jáimez
Aims: Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is a life-threatening entity with a highly heterogeneous genetic background. Cardiac magnetic resonance (CMR) imaging can identify fibrofatty scar by late gadolinium enhancement (LGE). Our aim is to investigate genotype–phenotype correlation in ARVC/D mutation carriers, focusing on CMR-LGE and myocardial fibrosis patterns. Methods and results: A cohort of 44 genotyped patients, 33 with definite and 11 with borderline ARVC/D diagnosis, was characterized using CMR and divided into groups according to their genetic condition (desmosomal, non-desmosomal mutation, or negative). We collected information on cardiac volumes and function, as well as LGE pattern and extension. In addition, available ventricular myocardium samples from patients with pathogenic gene mutations were histopathologically analysed. Half of the patients were women, with a mean age of 41.6 ± 17.5 years. Next-generation sequencing identified a potential pathogenic mutation in 71.4% of the probands. The phenotype varied according to genetic status, with non-desmosomal male patients showing lower left ventricular (LV) systolic function. LV fibrosis was similar between groups, but distribution in non-desmosomal patients was frequently located at the posterolateral LV wall; a characteristic LV subepicardial circumferential LGE pattern was significantly associated with ARVC/D caused by desmin mutation. Histological analysis showed increased fibrillar connective tissue and intercellular space in all the samples. Conclusion: Desmosomal and non-desmosomal mutation carriers showed different morphofunctional features but similar LV LGE presence. DES mutation carriers can be identified by a specific and extensive LV subepicardial circumferential LGE pattern. Further studies should investigate the specificity of LGE in ARVC/D.

1 June 2018 in Archivos de Bronconeumología
Verified
Journal Article
Closed access
LFLaura Fernández-Navarro
Laura Fernández-Navarro
EMElena Moya-Sánchez
Elena Moya-Sánchez
DSDiego Segura-Rodríguez
Diego Segura-Rodríguez
EREduardo Ruiz-Carazo
Eduardo Ruiz-Carazo

3 November 2026 in Pediatric Cardiology
Verified
Journal Article
Closed access
PDF file
CCCristina Cánovas-Galindo
Cristina Cánovas-Galindo
DSDiego Segura-Rodríguez
Diego Segura-Rodríguez
RLRaquel Ladrón-Abia
Raquel Ladrón-Abia
EEEDUARDO MORENO ESCOBAR
EDUARDO MORENO ESCOBAR

8 October 2024 in medRxiv
Verified
Preprint
Open access
PDF file
GRGarcía-Orta Rocío
García-Orta Rocío
GMGonzález Molina Mercedes
González Molina Mercedes
UIUribe Morales Inés
Uribe Morales Inés
TLTorres Quintero Lucía
Torres Quintero Lucía
RJRodríguez Torres Diego J.
Rodríguez Torres Diego J.
EEEDUARDO MORENO ESCOBAR
EDUARDO MORENO ESCOBAR
Background: The objective of the study was to determine perioperative clinical and echocardiographic factors associated with pulmonary hypertension (PH) during long-term follow-up of patients with severe primary mitral regurgitation (MR) after mitral valve replacement surgery and its prognostic repercussions. Methods: Prospective cohort of consecutive patients undergoing mitral valve replacement between January 2005 and January 2015 and followed for ≥3 years. Main exclusion criteria were receipt of mitral repair surgery and the presence of mitral stenosis. The main outcome was a systolic pulmonary pressure (SPAP) by echocardiography >50 mmHg at least 12 months’ post-surgery. Results: 106 patients, 46% male, mean age of 61.7±11 yrs. and median follow-up of 8.8 [6- 16] yrs. SPAP was >50 mmHg in 33% of patients. Predictors identified by multivariate analysis were diabetes (OR 8.3, 95%CI 1.1-73.9), persistent atrial fibrillation (OR 4.2, 95%CI 1.1-20.6), non-rheumatic MR (OR 7.3, 95%CI 1.1-45.5), prosthesis gradient, (OR 2.8, 95%CI 1.3-5.7), patient-prosthesis mismatch (OR 16.9, 95%CI 1.2-234), and preoperative SPAP ≥50 mmHg (OR 19.3, 95%CI 3.4-107). Patients with PH had higher hospitalization (78.8 % vs. 37%, p<0.001) and mortality (72,4% vs. 19,7%, p<0.001) rates. The 10-year survival rate was 83% in patients without PH versus 30% in those with PH (p<0.001). Conclusions: Persistent PH is a frequent and serious long-term complication of valve replacement for severe mitral regurgitation. It is associated with a poor prognosis and is related to preoperative pulmonary pressure. Surgery could be considered in candidates for mitral valve replacement with moderate PH, especially in the presence of atrial fibrillation. Clinical perspective: What is already known on this topic: Pulmonary hypertension is not reversed in an important subset of patients with severe mitral regurgitation after mitral valve replacement surgery and it is associated with a poor prognosis. No prospective study has been published on preoperative factors associated with this condition. The prevalence and prognosis of postoperative PH has not been precisely described. What this study adds: Persistent PH after valve replacement for severe mitral regurgitation is common and its prognosis is ominous. Preoperative SPAP ≥50 mmHg and persistent atrial fibrillation are the main predictive factors. The results of this study might affect clinical practice suggesting considering surgery in this population (not only in mitral valve repair) when SPAP ≥50 mmHg, especially if persistent atrial fibrillation. Graphical

2 November 2026 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Open access
DSDiego Segura-Rodríguez
Diego Segura-Rodríguez
MMMiguel Morales-García
Miguel Morales-García
EEEDUARDO MORENO ESCOBAR
EDUARDO MORENO ESCOBAR
PFPilar Martín de la Fuente
Pilar Martín de la Fuente
FGFrancisco Burillo Gómez
Francisco Burillo Gómez
RGRocío García-Orta
Rocío García-Orta
Aims: Bicuspid aortic valve-associated aortopathy (BAVA) and heritable thoracic aortic disease (HTAD) share clinical manifestations but may represent distinct pathophysiological entities. We aimed to compare morphological and haemodynamic profiles between both groups using cardiovascular magnetic resonance (CMR) imaging and non-invasive systemic haemodynamic assessment. Methods and results: A total of 185 patients (111 BAVA, 74 HTAD) were prospectively enrolled. CMR 4D-flow assessed aortic distensibility (ADCMR), pulse wave velocity (PWVCMR), global wall shear stress (WSSCMR), and energy loss (ELCMR). Oscillometry assessed systemic PWVM, augmentation index (AIxM), and systemic vascular resistance (SVRM). Composite adverse aortic events (AAEs) comprised acute aortic syndrome, cardiovascular death, or guideline diameter-based indication for surgery over 42.1 ± 17.6 months. BAVA showed greater tubular ascending aorta and sinotubular junction dilation, ascending aorta WSSCMR (0.42 ± 0.18 vs. 0.28 ± 0.12 Pa, P = 0.020), ELCMR (19.8 ± 8.4 vs. 12.3 ± 6.1 mW, P < 0.001), and ADCMR (6.1 ± 3.5 vs. 4.8 ± 2.9 × 10⁻³ mmHg⁻¹, P = 0.023), yet lower systemic stiffness than HTAD (PWVM 6.2 ± 1.7 vs. 7.8 ± 2.1 m/s; AIxM 12.1 ± 7.6 vs. 18.4 ± 9.2%; both P < 0.001). AAE rates were similar. In exploratory aetiology-specific analyses, ascending aorta WSSCMR was associated with events in BAVA (HR 8.92, 95% CI 2.85–27.95) and systemic PWVM in HTAD (HR 2.16, 95% CI 1.30–3.57). Conclusion: BAVA and HTAD show distinct morphological and haemodynamic phenotypes: BAVA with focal dilation, elevated WSSCMR/ELCMR and preserved systemic function; HTAD with reduced local distensibility and greater systemic stiffness. These aetiology-specific predictors are exploratory and require external validation.

27 July 2019 in BMJ Case Reports
Verified
Journal Article
Closed access
EEEduardo Moreno Escobar
Eduardo Moreno Escobar
DSDiego Segura-Rodriguez
Diego Segura-Rodriguez
DTDiego José Rodriguez Torres
Diego José Rodriguez Torres
RORocio Garcia Orta
Rocio Garcia Orta
We report the case of a patient diagnosed with extreme tetralogy of Fallot who received subclavian-pulmonary artery shunt at the age of 3 years and underwent corrective surgery at the age of 16 years. The patient developed progressive effort dyspnea and left ventricular dysfunction from the age of 40 years. The exploratory finding of a continuous jugular and left subclavian murmur prompted an echocardiographic study that evidenced a continuous flow in the suprasternal view. CT study confirmed the patency of the surgical subclavian-pulmonary artery shunt, which was percutaneously embolised with the implantation of an Amplatzer plug, with a good final outcome and no residual flow. The patient showed a satisfactory development with clinical improvement, decreased left ventricular volume and enhanced left ventricular function.